According to a recent survey, global annual spending on pharmaceuticals is set to reach almost 1.2 trillion US dollars in 2016. The so-called pharmerging markets play an important role in this development. Growing population, rising incomes, and improved access to drugs are amongst the reasons for these markets reaching 30 per cent of global expenses by 2016. Jérôme Freissmuth at Robert Bosch GmbH explains how rapid development of emerging markets, progress in drug research, the rise in generics production, the availability of high-potency drugs, and innovations in manufacturing processes, will sustainably modify the global pharmaceutical landscape.

https://international-pharma.com/wp-content/uploads/2013/06/2-The-Future-of-Pharmaceutical-Manufacturing.pdf